LSTA has been in the news 362% more than usual
Sep 23, 2025, 2:32 PM
4.59%
What does LSTA do
Lisata Therapeutics, based in Basking Ridge, New Jersey, focuses on developing therapies for advanced solid tumors, with its lead candidate LSTA1 enhancing anti-cancer drug penetration in tumors. The company also explores CD34+ cell therapy for various diseases, including critical limb ischemia and diabetic kidney disease.
LSTA has been in the news recently: LISATA THERAPEUTICS is not directly mentioned in the provided information, but related entities like MBX Biosciences, Inc. experienced stock growth following positive results from a Phase 2 trial for a new treatment. Additionally, MLAB Biosciences appointed two new members to its Scientific Advisory Board to further develop its muscle regeneration therapy.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.